Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBIS-II DCIS: tamoxifen versus anastrozole in postmenopausal women with hormone receptor-positive DCIS
ISRCTN37546358Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- May 2003
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in ductal carcinoma in situ (DCIS) and breast cancer comparing Tamoxifen arm with Anastrozole arm (2 arms). Primary endpoint: All new and recurrent breast cancer. Started May 2003; status: completed.
02
Drugs
tamoxifenanastrozole
03
Conditions
ductal carcinoma in situ (DCIS)breast cancer
Beyond the preview
Go deeper on ISRCTN37546358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37546358.